These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30958715)

  • 1. Effectively Initiating and Maintaining Anticoagulation in Patients With Atrial Fibrillation.
    Wang TY
    Circulation; 2019 Apr; 139(15):1763-1765. PubMed ID: 30958715
    [No Abstract]   [Full Text] [Related]  

  • 2. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future.
    Wehbe RM; Yadlapati A
    Tex Heart Inst J; 2016 Aug; 43(4):287-90. PubMed ID: 27547134
    [No Abstract]   [Full Text] [Related]  

  • 4. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants.
    Raparelli V; Proietti M; Cangemi R; Lip GY; Lane DA; Basili S
    Thromb Haemost; 2017 Jan; 117(2):209-218. PubMed ID: 27831592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's New in Anticoagulation.
    Razavi JE; Safavi-Naeini P; Razavi M
    Tex Heart Inst J; 2016 Oct; 43(5):419-421. PubMed ID: 27777526
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.
    Lip GY; Bongiorni MG; Dobreanu D; Lewalter T; Hastrup Svendsen J; Blomström-Lundqvist C;
    Europace; 2013 Oct; 15(10):1526-32. PubMed ID: 24072770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
    Martinez C; Katholing A; Wallenhorst C; Freedman SB
    Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation therapy in elderly patients with atrial fibrillation: results from the Registry of Atrial Fibrillation To Investigate the Implementation of New Guidelines (RAFTING).
    Pipilis A; Farmakis D; Kaliambakos S; Goudevenos J; Lekakis J;
    J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):545-549. PubMed ID: 26825445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation of elderly patients at high risk for falls with atrial fibrillation.
    Med Lett Drugs Ther; 2017 Feb; 59(1515):35-36. PubMed ID: 28222062
    [No Abstract]   [Full Text] [Related]  

  • 12. Important Changes for Practicing Physicians in the Focused Atrial Fibrillation Guideline Update.
    Link MS
    Circulation; 2020 Dec; 142(25):2399-2401. PubMed ID: 30704308
    [No Abstract]   [Full Text] [Related]  

  • 13. Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation.
    Hua H; Sur N; Lee L; Chaturvedi S
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105474. PubMed ID: 33242786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.
    Gray MP; Saba S; Zhang Y; Hernandez I
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation: Anticoagulation for AF: can we GRASP-AF patients?
    Lane DA; Lip GY
    Nat Rev Cardiol; 2013 May; 10(5):241-2. PubMed ID: 23546443
    [No Abstract]   [Full Text] [Related]  

  • 16. Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk.
    Tomlin AM; Lloyd HS; Tilyard MW
    Eur J Prev Cardiol; 2017 Feb; 24(3):311-319. PubMed ID: 27798365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions.
    Di Biase L
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892528
    [No Abstract]   [Full Text] [Related]  

  • 18. Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.
    Steinberg BA; Greiner MA; Hammill BG; Curtis LH; Benjamin EJ; Heckbert SR; Piccini JP
    Cardiovasc Ther; 2015 Aug; 33(4):177-83. PubMed ID: 25930214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing Use of Anticoagulants in Germany and Its Impact on Hospitalization for Intracranial Bleeding.
    Gülker JE; Kröger K; Kowall B; Dingelstadt M; Stang A
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004470. PubMed ID: 29748354
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L; DeLosSantos M; Smotherman C
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.